Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Norcross EW, Sanders ME, Moore QC 3rd, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

2.

Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Green SN, Sanders M, Moore QC 3rd, Norcross EW, Monds KS, Caballero AR, McDaniel LS, Robinson SA, Onwubiko C, O'Callaghan RJ, Marquart ME.

Invest Ophthalmol Vis Sci. 2008 Jan;49(1):290-4. doi: 10.1167/iovs.07-0492.

3.

Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Sanders ME, Taylor S, Tullos N, Norcross EW, Moore QC 3rd, Thompson H, King LB, Marquart ME.

BMC Ophthalmol. 2013 Mar 11;13:8. doi: 10.1186/1471-2415-13-8.

4.

Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Sanders ME, Norcross EW, Moore QC 3rd, Fratkin J, Thompson H, Marquart ME.

J Ocul Pharmacol Ther. 2010 Dec;26(6):571-7. doi: 10.1089/jop.2010.0077. Epub 2010 Oct 29.

5.

Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2661-6.

6.

Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.

Lu J, Sun T, Hou H, Xu M, Gu T, Dong Y, Wang D, Chen P, Wu C, Liang C, Sun S, Jiang C, Kong W, Wu Y.

Immunol Invest. 2014;43(7):717-26. doi: 10.3109/08820139.2014.930478. Epub 2014 Jul 14.

PMID:
25020076
7.

Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.

Elhaik Goldman S, Dotan S, Talias A, Lilo A, Azriel S, Malka I, Portnoi M, Ohayon A, Kafka D, Ellis R, Elkabets M, Porgador A, Levin D, Azhari R, Swiatlo E, Ling E, Feldman G, Tal M, Dagan R, Mizrachi Nebenzahl Y.

Int J Mol Med. 2016 Apr;37(4):1127-38. doi: 10.3892/ijmm.2016.2512. Epub 2016 Mar 1.

PMID:
26935978
8.

Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R.

Clin Vaccine Immunol. 2012 Oct;19(10):1618-23. Epub 2012 Aug 8.

9.

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.

Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.

Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.

PMID:
21696869
10.

Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.

Reed JM, O'Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):604-8.

PMID:
15671288
11.

A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.

Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT.

Vaccine. 2011 Jul 26;29(33):5495-501. doi: 10.1016/j.vaccine.2011.05.051. Epub 2011 May 30.

12.
13.

Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.

Huo Z, Spencer O, Miles J, Johnson J, Holliman R, Sheldon J, Riches P.

Vaccine. 2004 Mar 12;22(9-10):1157-61.

PMID:
15003643
14.

Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.

Villena J, Medina M, Racedo S, Alvarez S.

J Microbiol Immunol Infect. 2010 Feb;43(1):1-10. doi: 10.1016/S1684-1182(10)60001-1. Epub 2010 Mar 29.

15.

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.

Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.

16.

Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.

Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.

J Infect Dis. 2001 Jan 15;183(2):253-260. Epub 2000 Dec 8.

PMID:
11110649
18.

Immunization with specific polysaccharide antigen reduces alterations in corneal proteoglycans during experimental slime-producing Staphylococcus epidermidis keratitis.

Georgakopoulos CD, Exarchou AM, Gartaganis SP, Kolonitsiou F, Anastassiou ED, Dimitracopoulos G, Hjerpe A, Theocharis AD, Karamanos NK.

Curr Eye Res. 2006 Feb;31(2):137-46.

PMID:
16500764
19.

L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.

Park S, Nahm MH.

PLoS One. 2013 Dec 31;8(12):e83810. doi: 10.1371/journal.pone.0083810. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/84458b5b-2bae-4d71-b003-7d584c1bfd8c.

20.

Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.

Liu Y, Wang H, Zhang S, Zeng L, Xu X, Wu K, Wang W, Yin N, Song Z, Zhang X, Yin Y.

Infect Immun. 2014 Apr;82(4):1666-75. doi: 10.1128/IAI.01391-13. Epub 2014 Feb 3.

Supplemental Content

Support Center